Patient engagement is a crucial responsibility of any gene therapy company if they're serious about progressing safe, effective, and meaningful therapies to patients. The 4th Gene Therapy Patient Engagement Summit […]

AI and computational science are revolutionizing the field of RNA therapeutic discovery, which is empowering biopharma companies to harness the potential of this technology. Join the conversation at the world’s […]

The entire cell therapy field is experiencing a shift towards allogeneic platforms as the potential to achieve a truly off-the-shelf, universal, and efficacious cell therapy offers great advantages such as […]

SAE Media Group’s 8th Annual Pre-Filled Syringes West Coast Conference will be back for 2024 in the West Coast to bring together device developers, biotech and big pharma. This year’s […]

Driving Process Robustness, Scalability, Speed & Affordability In the dynamic cell therapy landscape, where financial challenges continue to prevail, the emphasis on innovative process development becomes pivotal. Now, more than […]

Harnessing Integrative Structural Biology Techniques Including NMR, X-Ray Crystallography, Cryo-EM, & Cryo-ET to Determine 3D Structures of Pharmacologically Relevant Targets & Propel Drug Design Have you heard the boom created […]

The 6th Age-Related Disease Therapeutics Summit is returning to San Francisco in June, with 60+ participants including Eli Lilly, Takeda, and Turn Biosciences to dive deep into breakthroughs in cellular […]

Accelerate your capsid and payload design with the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) As a recent whitepaper by the Alliance for Regenerative Medicine cites capsid engineering […]

The highly anticipated World CDx Regulatory Affairs & Policy Summit, is set to debut in Boston from June 19-20, 2024. From tackling the complexities of LDT regulation and navigating the IVDR […]

Cell and gene therapies are revolutionizing healthcare, offering promising solutions from curative treatments to long-term remission rates. As these treatments enter the market, ensuring fair access while addressing coverage and […]

Regulatory guidelines and existing protocols to govern aspects of mRNA quality during development and manufacturing are still evolving, creating a lack of clarity and consensus amongst the mRNA community. Without […]

Welcome to the Future of Cell & Gene Therapy The 3rd In Vivo Cell Engineering & Gene Editing Summit is an annual event uniting C-level in vivo experts to facilitate […]

Fast-Track Your mRNA-Based Therapeutics & Vaccines from Discovery to Commercialization by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications As mRNA developments continue to dominate industry news, […]

The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma, biotech and academia to delve into the details of gamma delta biology and its various […]

There has been many exciting investments and advancements in the field, such as Atavistik Bio raising an additional $40 million to advance their small molecule therapeutics and Servier and Base4 […]

Optimize Safety & De-Risk Efficacy of Viral Vector-Based Gene Therapies The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies […]

With Eli Lilly's acquisition of Mablink and Novartis' investment in Tagworks, both centering on their innovative linker and conjugation technologies - optimizing linker chemistry and diversifying conjugation technologies to increase stability and selectivity are becoming increasingly more […]

Delivering on the Promise of Precision Medicine with Digital Measures in Neurology Harnessing More Quantitative, Objective & Less Invasive Measures to Reduce Costs & Improve Neurology Patient Experience 2023 welcomed SV95C as […]

Exclusively dedicated to uniting AD, QC, and CMC leaders the 3rd Oligonucleotide CMC & Analytical Development Summit is the only industry-led meeting solving your impurity, regulatory, and cost-efficiency challenges in […]

Bringing together technical experts, the 3rd Cell Therapy Analytical Development Summit Europe, is the definitive summit dedicated to defining and refining analytics to ensure the swift progression of highly efficacious products through […]

The Wearable Injectors and Connected Devices event is the only conference that discusses both wearable injectors and connected devices in one event. Over two days, we bring together executives within […]

Major moves in pharma and biotech partnering are reshaping the landscape. For ADC companies, the challenge lies in standing out, validating their offerings, and securing clinical-ready assets amidst this whirlwind […]

SAE Media Group are proud to announce the inaugural Pre-Filled Syringes Connect event taking place on the 11th and 12th of September in Boston. As a new addition to SAE's […]

The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further approvals set for this year, 2024 […]

Develop, characterize, and validate robust analytical tools that demonstrate safety, efficacy, and regulatory compliance of genome editing therapies As CRISPR-based therapies become ever-complex, drug developers urgently need to innovate the […]

Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into the Clinic & Beyond The mRNA manufacturing industry […]

With cutting-edge strategies and industry insights, the 2nd ADC Process Development Summit is back with a mission to boost conjugation yield, optimize purification, and streamline production to meet regulatory standards […]

The race to target the remaining RAS mutants continues, with over 24 clinical and 70 pre-clinical stage programs striving for first- and best-in-class. Now more than ever, we are witnessing […]

Join us for an exploration of accelerating drug development, streamlining clinical trials and enhancing supply chain efficiency to elevate patient care across the entire value stream at the AI for […]

With Rezdiffra’s approval, GLPs moving into the space, and the wave of promising therapeutics in phrase I-III trials, MASH therapeutics have seen an unprecedented boom in recent months. Don't miss […]